TY - JOUR
T1 - COVID-19 pandemic effect on early pregnancy
T2 - are miscarriage rates altered, in asymptomatic women?
AU - Rotshenker-Olshinka, Keren
AU - Volodarsky-Perel, Alexander
AU - Steiner, Naama
AU - Rubenfeld, Eryn
AU - Dahan, Michael H.
N1 - Publisher Copyright:
© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2021/3/1
Y1 - 2021/3/1
N2 - Purpose: To evaluate the effect of the COVID-19 pandemic state on early, first-trimester pregnancies. Methods: A retrospective cohort study conducted at a university-affiliated fertility center in Montreal, Quebec, since the COVID-19 shut down, March 13 until May 6, 2020. Included: all women who came for a first-trimester viability scan during the study period (Study group) and between March 1, 2019 and May 17, 2019, approximately one year prior (Control). The study population denied symptoms of COVID-19. We reviewed all first trimester scans. Early first-trimester pregnancy outcomes (Viable pregnancy, arrested pregnancy including biochemical pregnancy loss and miscarriage, and ectopic pregnancy) were measured as total number and percentage. A multivariate analysis was performed to control for other potentially significant variables, as was a power analysis supporting sample size. Results: 113 women came for a first-trimester viability scan in the study period, and 172 in the control period (5–11 weeks gestational age), mean maternal age 36.5 ± 4.5 and 37.2 ± 5.4 years (p = 0.28). Viable clinical pregnancy rate was not different between the two groups (76.1 vs. 80.2% in the pandemic and pre-pandemic groups p = 0.41). No significant difference was seen in the total number of arrested pregnancies (defined as the sum of biochemical, 1st trimester miscarriages, and blighted ova) (22.1 vs. 16.9% p = 0.32), or in each type of miscarriage. Conclusion: The COVID-19 pandemic environment does not seem to affect early first-trimester miscarriage rates in asymptomatic patients.
AB - Purpose: To evaluate the effect of the COVID-19 pandemic state on early, first-trimester pregnancies. Methods: A retrospective cohort study conducted at a university-affiliated fertility center in Montreal, Quebec, since the COVID-19 shut down, March 13 until May 6, 2020. Included: all women who came for a first-trimester viability scan during the study period (Study group) and between March 1, 2019 and May 17, 2019, approximately one year prior (Control). The study population denied symptoms of COVID-19. We reviewed all first trimester scans. Early first-trimester pregnancy outcomes (Viable pregnancy, arrested pregnancy including biochemical pregnancy loss and miscarriage, and ectopic pregnancy) were measured as total number and percentage. A multivariate analysis was performed to control for other potentially significant variables, as was a power analysis supporting sample size. Results: 113 women came for a first-trimester viability scan in the study period, and 172 in the control period (5–11 weeks gestational age), mean maternal age 36.5 ± 4.5 and 37.2 ± 5.4 years (p = 0.28). Viable clinical pregnancy rate was not different between the two groups (76.1 vs. 80.2% in the pandemic and pre-pandemic groups p = 0.41). No significant difference was seen in the total number of arrested pregnancies (defined as the sum of biochemical, 1st trimester miscarriages, and blighted ova) (22.1 vs. 16.9% p = 0.32), or in each type of miscarriage. Conclusion: The COVID-19 pandemic environment does not seem to affect early first-trimester miscarriage rates in asymptomatic patients.
KW - COVID-19
KW - Early pregnancy
KW - First-trimester miscarriage
KW - Miscarriage
KW - Pandemic
UR - https://www.scopus.com/pages/publications/85095752283
U2 - 10.1007/s00404-020-05848-0
DO - 10.1007/s00404-020-05848-0
M3 - Article
C2 - 33169234
AN - SCOPUS:85095752283
SN - 0932-0067
VL - 303
SP - 839
EP - 845
JO - Archives of Gynecology and Obstetrics
JF - Archives of Gynecology and Obstetrics
IS - 3
ER -